The global market for Organoids LNP was valued at US$ 125 million in the year 2024 and is projected to reach a revised size of US$ 278 million by 2031, growing at a CAGR of 12.3% during the forecast period.

Organoids LNP Market

Organoids LNP (Organoids Lipid Nanoparticles) represent an emerging delivery platform that integrates lipid nanoparticle (LNP) technology with organoid systems. This approach combines the physiological complexity of three-dimensional organoids with the efficient nucleic acid delivery capabilities of LNPs, enabling the targeted transport of drugs, gene-editing tools (such as mRNA, siRNA, and CRISPR-Cas systems), and growth factors. By optimizing lipid composition, particle size, surface charge, and ligand modifications, Organoids LNPs allow for precise modulation of cellular populations within organoids. This technology plays a vital role in disease modeling, personalized drug screening, gene therapy validation, and regenerative medicine. It signifies a major step forward in translating nanocarrier delivery systems into physiologically relevant microenvironments, offering new prospects for innovative drug discovery and precision therapeutics.The average gross profit margin of this product is 33%.

The growth of the Organoids LNP market is primarily driven by the rapid advancements in regenerative medicine, gene therapy, and high-throughput drug screening. With organoids being increasingly applied to liver, intestine, brain, lung, and tumor models, the demand for efficient delivery systems is expanding rapidly. Leveraging the success of LNPs in mRNA vaccines and gene therapy, this technology is becoming the preferred platform for nucleic acid and protein delivery in organoid systems. Furthermore, the integration of artificial intelligence and computational chemistry has enhanced the precision of LNP design and targeting, accelerating the commercialization and translational adoption of Organoids LNP technology.

The key challenges for Organoids LNP technology lie in achieving efficient diffusion and homogeneous delivery within the complex three-dimensional structures of organoids. Unlike 2D cultures, organoids’ multilayered architecture and extracellular matrix components can limit LNP penetration and stability. Additionally, concerns regarding lipid material immunogenicity and biodegradability remain major barriers to clinical translation. The lack of unified industry standards and reproducibility issues across different experimental systems pose further risks to commercialization. Moreover, regulatory uncertainty surrounding the safety assessment of novel nanomaterials in biological models adds to the development complexity.

Downstream demand is driven by ongoing investments from pharmaceutical companies, biotech firms, and academic research institutions in drug screening, toxicological evaluation, and gene-editing validation. Particularly in tumor and immune organoid studies, reliance on LNPs as precise delivery vehicles is rapidly increasing. The rapid expansion of mRNA therapeutics and cell therapy products is further elevating the need for advanced organoid-compatible delivery systems. In the future, Organoids LNPs will integrate closely with bio-printed organ systems and multi-omics platforms, serving as a critical bridge for innovative drug development and personalized medicine.

The key raw materials for Organoids LNPs include cationic lipids, neutral lipids, phospholipids, cholesterol, and PEGylated lipids. The purity, particle control, and chemical modification levels of these components directly determine nanoparticle encapsulation efficiency, stability, and biocompatibility. The upstream supply chain remains concentrated among a limited number of advanced manufacturers with GMP-grade synthesis capabilities, such as Avanti Polar Lipids, Croda, Merck, and Nippon Fine Chemical. The emergence of bio-based lipids and biodegradable polyester materials has recently introduced sustainable alternatives, enhancing the suitability of LNPs for long-term organoid applications.

This report aims to provide a comprehensive presentation of the global market for Organoids LNP, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organoids LNP.

The Organoids LNP market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Organoids LNP market comprehensively. Regional market sizes, concerning products by Type, by Application, by Organoid Model Type and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Organoids LNP companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Organoids LNP Market Report

Report Metric	Details
Report Name	Organoids LNP Market
Accounted market size in year	US$ 125 million
Forecasted market size in 2031	US$ 278 million
CAGR	12.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Solid Lipid Nanoparticles (SLN) Nanostructured Lipid Carriers (NLC) Liposomes Other
Segment by Organoid Model Type	Liver Organoids Intestinal Organoids Kidney Organoids Brain Organoids Other
Segment by Application Area	Drug Discovery Gene Therapy Research Regenerative Medicine Personalized Medicine
Segment by Application	mRNA Delivery siRNA/miRNA Delivery Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Croda, Evonik Health Care, Cytiva, STEMCELL Technologies, Acuitas Therapeutics, Merck KGaA, Corden Pharma, Genevant Sciences, Nippon Fine Chemical, Polymun Scientific, Catalent, Creative Biolabs, GenScript, WuXi STA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Organoid Model Type etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Organoids LNP company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Organoids LNP Market growing?

Ans: The Organoids LNP Market witnessing a CAGR of 12.3% during the forecast period 2025-2031.

What is the Organoids LNP Market size in 2031?

Ans: The Organoids LNP Market size in 2031 will be US$ 278 million.

Who are the main players in the Organoids LNP Market report?

Ans: The main players in the Organoids LNP Market are Croda, Evonik Health Care, Cytiva, STEMCELL Technologies, Acuitas Therapeutics, Merck KGaA, Corden Pharma, Genevant Sciences, Nippon Fine Chemical, Polymun Scientific, Catalent, Creative Biolabs, GenScript, WuXi STA

What are the Application segmentation covered in the Organoids LNP Market report?

Ans: The Applications covered in the Organoids LNP Market report are mRNA Delivery, siRNA/miRNA Delivery, Other

What are the Type segmentation covered in the Organoids LNP Market report?

Ans: The Types covered in the Organoids LNP Market report are Liver Organoids, Intestinal Organoids, Kidney Organoids, Brain Organoids, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Organoids LNP Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Solid Lipid Nanoparticles (SLN)

1.2.3 Nanostructured Lipid Carriers (NLC)

1.2.4 Liposomes

1.2.5 Other

1.3 Market by Organoid Model Type

1.3.1 Global Organoids LNP Market Size Growth Rate by Organoid Model Type: 2020 VS 2024 VS 2031

1.3.2 Liver Organoids

1.3.3 Intestinal Organoids

1.3.4 Kidney Organoids

1.3.5 Brain Organoids

1.3.6 Other

1.4 Market by Application Area

1.4.1 Global Organoids LNP Market Size Growth Rate by Application Area: 2020 VS 2024 VS 2031

1.4.2 Drug Discovery

1.4.3 Gene Therapy Research

1.4.4 Regenerative Medicine

1.4.5 Personalized Medicine

1.5 Market by Application

1.5.1 Global Organoids LNP Market Growth by Application: 2020 VS 2024 VS 2031

1.5.2 mRNA Delivery

1.5.3 siRNA/miRNA Delivery

1.5.4 Other

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Organoids LNP Market Perspective (2020-2031)

2.2 Global Organoids LNP Growth Trends by Region

2.2.1 Global Organoids LNP Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Organoids LNP Historic Market Size by Region (2020-2025)

2.2.3 Organoids LNP Forecasted Market Size by Region (2026-2031)

2.3 Organoids LNP Market Dynamics

2.3.1 Organoids LNP Industry Trends

2.3.2 Organoids LNP Market Drivers

2.3.3 Organoids LNP Market Challenges

2.3.4 Organoids LNP Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Organoids LNP Players by Revenue

3.1.1 Global Top Organoids LNP Players by Revenue (2020-2025)

3.1.2 Global Organoids LNP Revenue Market Share by Players (2020-2025)

3.2 Global Top Organoids LNP Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Organoids LNP Revenue

3.4 Global Organoids LNP Market Concentration Ratio

3.4.1 Global Organoids LNP Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Organoids LNP Revenue in 2024

3.5 Global Key Players of Organoids LNP Head office and Area Served

3.6 Global Key Players of Organoids LNP, Product and Application

3.7 Global Key Players of Organoids LNP, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Organoids LNP Breakdown Data by Type

4.1 Global Organoids LNP Historic Market Size by Type (2020-2025)

4.2 Global Organoids LNP Forecasted Market Size by Type (2026-2031)

5 Organoids LNP Breakdown Data by Application

5.1 Global Organoids LNP Historic Market Size by Application (2020-2025)

5.2 Global Organoids LNP Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Organoids LNP Market Size (2020-2031)

6.2 North America Organoids LNP Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Organoids LNP Market Size by Country (2020-2025)

6.4 North America Organoids LNP Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Organoids LNP Market Size (2020-2031)

7.2 Europe Organoids LNP Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Organoids LNP Market Size by Country (2020-2025)

7.4 Europe Organoids LNP Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Organoids LNP Market Size (2020-2031)

8.2 Asia-Pacific Organoids LNP Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Organoids LNP Market Size by Region (2020-2025)

8.4 Asia-Pacific Organoids LNP Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Organoids LNP Market Size (2020-2031)

9.2 Latin America Organoids LNP Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Organoids LNP Market Size by Country (2020-2025)

9.4 Latin America Organoids LNP Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Organoids LNP Market Size (2020-2031)

10.2 Middle East & Africa Organoids LNP Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Organoids LNP Market Size by Country (2020-2025)

10.4 Middle East & Africa Organoids LNP Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Croda

11.1.1 Croda Company Details

11.1.2 Croda Business Overview

11.1.3 Croda Organoids LNP Introduction

11.1.4 Croda Revenue in Organoids LNP Business (2020-2025)

11.1.5 Croda Recent Development

11.2 Evonik Health Care

11.2.1 Evonik Health Care Company Details

11.2.2 Evonik Health Care Business Overview

11.2.3 Evonik Health Care Organoids LNP Introduction

11.2.4 Evonik Health Care Revenue in Organoids LNP Business (2020-2025)

11.2.5 Evonik Health Care Recent Development

11.3 Cytiva

11.3.1 Cytiva Company Details

11.3.2 Cytiva Business Overview

11.3.3 Cytiva Organoids LNP Introduction

11.3.4 Cytiva Revenue in Organoids LNP Business (2020-2025)

11.3.5 Cytiva Recent Development

11.4 STEMCELL Technologies

11.4.1 STEMCELL Technologies Company Details

11.4.2 STEMCELL Technologies Business Overview

11.4.3 STEMCELL Technologies Organoids LNP Introduction

11.4.4 STEMCELL Technologies Revenue in Organoids LNP Business (2020-2025)

11.4.5 STEMCELL Technologies Recent Development

11.5 Acuitas Therapeutics

11.5.1 Acuitas Therapeutics Company Details

11.5.2 Acuitas Therapeutics Business Overview

11.5.3 Acuitas Therapeutics Organoids LNP Introduction

11.5.4 Acuitas Therapeutics Revenue in Organoids LNP Business (2020-2025)

11.5.5 Acuitas Therapeutics Recent Development

11.6 Merck KGaA

11.6.1 Merck KGaA Company Details

11.6.2 Merck KGaA Business Overview

11.6.3 Merck KGaA Organoids LNP Introduction

11.6.4 Merck KGaA Revenue in Organoids LNP Business (2020-2025)

11.6.5 Merck KGaA Recent Development

11.7 Corden Pharma

11.7.1 Corden Pharma Company Details

11.7.2 Corden Pharma Business Overview

11.7.3 Corden Pharma Organoids LNP Introduction

11.7.4 Corden Pharma Revenue in Organoids LNP Business (2020-2025)

11.7.5 Corden Pharma Recent Development

11.8 Genevant Sciences

11.8.1 Genevant Sciences Company Details

11.8.2 Genevant Sciences Business Overview

11.8.3 Genevant Sciences Organoids LNP Introduction

11.8.4 Genevant Sciences Revenue in Organoids LNP Business (2020-2025)

11.8.5 Genevant Sciences Recent Development

11.9 Nippon Fine Chemical

11.9.1 Nippon Fine Chemical Company Details

11.9.2 Nippon Fine Chemical Business Overview

11.9.3 Nippon Fine Chemical Organoids LNP Introduction

11.9.4 Nippon Fine Chemical Revenue in Organoids LNP Business (2020-2025)

11.9.5 Nippon Fine Chemical Recent Development

11.10 Polymun Scientific

11.10.1 Polymun Scientific Company Details

11.10.2 Polymun Scientific Business Overview

11.10.3 Polymun Scientific Organoids LNP Introduction

11.10.4 Polymun Scientific Revenue in Organoids LNP Business (2020-2025)

11.10.5 Polymun Scientific Recent Development

11.11 Catalent

11.11.1 Catalent Company Details

11.11.2 Catalent Business Overview

11.11.3 Catalent Organoids LNP Introduction

11.11.4 Catalent Revenue in Organoids LNP Business (2020-2025)

11.11.5 Catalent Recent Development

11.12 Creative Biolabs

11.12.1 Creative Biolabs Company Details

11.12.2 Creative Biolabs Business Overview

11.12.3 Creative Biolabs Organoids LNP Introduction

11.12.4 Creative Biolabs Revenue in Organoids LNP Business (2020-2025)

11.12.5 Creative Biolabs Recent Development

11.13 GenScript

11.13.1 GenScript Company Details

11.13.2 GenScript Business Overview

11.13.3 GenScript Organoids LNP Introduction

11.13.4 GenScript Revenue in Organoids LNP Business (2020-2025)

11.13.5 GenScript Recent Development

11.14 WuXi STA

11.14.1 WuXi STA Company Details

11.14.2 WuXi STA Business Overview

11.14.3 WuXi STA Organoids LNP Introduction

11.14.4 WuXi STA Revenue in Organoids LNP Business (2020-2025)

11.14.5 WuXi STA Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

CRODA

Evonik Health Care

Cytiva

StemCell Technologies

List of Tables

Table 1. Global Organoids LNP Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Solid Lipid Nanoparticles (SLN)

Table 3. Key Players of Nanostructured Lipid Carriers (NLC)

Table 4. Key Players of Liposomes

Table 5. Key Players of Other

Table 6. Global Organoids LNP Market Size Growth Rate by Organoid Model Type (US$ Million): 2020 VS 2024 VS 2031

Table 7. Key Players of Liver Organoids

Table 8. Key Players of Intestinal Organoids

Table 9. Key Players of Kidney Organoids

Table 10. Key Players of Brain Organoids

Table 11. Key Players of Other

Table 12. Global Organoids LNP Market Size Growth Rate by Application Area (US$ Million): 2020 VS 2024 VS 2031

Table 13. Key Players of Drug Discovery

Table 14. Key Players of Gene Therapy Research

Table 15. Key Players of Regenerative Medicine

Table 16. Key Players of Personalized Medicine

Table 17. Global Organoids LNP Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 18. Global Organoids LNP Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 19. Global Organoids LNP Market Size by Region (2020-2025) & (US$ Million)

Table 20. Global Organoids LNP Market Share by Region (2020-2025)

Table 21. Global Organoids LNP Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 22. Global Organoids LNP Market Share by Region (2026-2031)

Table 23. Organoids LNP Market Trends

Table 24. Organoids LNP Market Drivers

Table 25. Organoids LNP Market Challenges

Table 26. Organoids LNP Market Restraints

Table 27. Global Organoids LNP Revenue by Players (2020-2025) & (US$ Million)

Table 28. Global Organoids LNP Market Share by Players (2020-2025)

Table 29. Global Top Organoids LNP Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organoids LNP as of 2024)

Table 30. Ranking of Global Top Organoids LNP Companies by Revenue (US$ Million) in 2024

Table 31. Global 5 Largest Players Market Share by Organoids LNP Revenue (CR5 and HHI) & (2020-2025)

Table 32. Global Key Players of Organoids LNP, Headquarters and Area Served

Table 33. Global Key Players of Organoids LNP, Product and Application

Table 34. Global Key Players of Organoids LNP, Date of Enter into This Industry

Table 35. Mergers & Acquisitions, Expansion Plans

Table 36. Global Organoids LNP Market Size by Type (2020-2025) & (US$ Million)

Table 37. Global Organoids LNP Revenue Market Share by Type (2020-2025)

Table 38. Global Organoids LNP Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 39. Global Organoids LNP Revenue Market Share by Type (2026-2031)

Table 40. Global Organoids LNP Market Size by Application (2020-2025) & (US$ Million)

Table 41. Global Organoids LNP Revenue Market Share by Application (2020-2025)

Table 42. Global Organoids LNP Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 43. Global Organoids LNP Revenue Market Share by Application (2026-2031)

Table 44. North America Organoids LNP Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. North America Organoids LNP Market Size by Country (2020-2025) & (US$ Million)

Table 46. North America Organoids LNP Market Size by Country (2026-2031) & (US$ Million)

Table 47. Europe Organoids LNP Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Europe Organoids LNP Market Size by Country (2020-2025) & (US$ Million)

Table 49. Europe Organoids LNP Market Size by Country (2026-2031) & (US$ Million)

Table 50. Asia-Pacific Organoids LNP Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 51. Asia-Pacific Organoids LNP Market Size by Region (2020-2025) & (US$ Million)

Table 52. Asia-Pacific Organoids LNP Market Size by Region (2026-2031) & (US$ Million)

Table 53. Latin America Organoids LNP Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 54. Latin America Organoids LNP Market Size by Country (2020-2025) & (US$ Million)

Table 55. Latin America Organoids LNP Market Size by Country (2026-2031) & (US$ Million)

Table 56. Middle East & Africa Organoids LNP Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 57. Middle East & Africa Organoids LNP Market Size by Country (2020-2025) & (US$ Million)

Table 58. Middle East & Africa Organoids LNP Market Size by Country (2026-2031) & (US$ Million)

Table 59. Croda Company Details

Table 60. Croda Business Overview

Table 61. Croda Organoids LNP Product

Table 62. Croda Revenue in Organoids LNP Business (2020-2025) & (US$ Million)

Table 63. Croda Recent Development

Table 64. Evonik Health Care Company Details

Table 65. Evonik Health Care Business Overview

Table 66. Evonik Health Care Organoids LNP Product

Table 67. Evonik Health Care Revenue in Organoids LNP Business (2020-2025) & (US$ Million)

Table 68. Evonik Health Care Recent Development

Table 69. Cytiva Company Details

Table 70. Cytiva Business Overview

Table 71. Cytiva Organoids LNP Product

Table 72. Cytiva Revenue in Organoids LNP Business (2020-2025) & (US$ Million)

Table 73. Cytiva Recent Development

Table 74. STEMCELL Technologies Company Details

Table 75. STEMCELL Technologies Business Overview

Table 76. STEMCELL Technologies Organoids LNP Product

Table 77. STEMCELL Technologies Revenue in Organoids LNP Business (2020-2025) & (US$ Million)

Table 78. STEMCELL Technologies Recent Development

Table 79. Acuitas Therapeutics Company Details

Table 80. Acuitas Therapeutics Business Overview

Table 81. Acuitas Therapeutics Organoids LNP Product

Table 82. Acuitas Therapeutics Revenue in Organoids LNP Business (2020-2025) & (US$ Million)

Table 83. Acuitas Therapeutics Recent Development

Table 84. Merck KGaA Company Details

Table 85. Merck KGaA Business Overview

Table 86. Merck KGaA Organoids LNP Product

Table 87. Merck KGaA Revenue in Organoids LNP Business (2020-2025) & (US$ Million)

Table 88. Merck KGaA Recent Development

Table 89. Corden Pharma Company Details

Table 90. Corden Pharma Business Overview

Table 91. Corden Pharma Organoids LNP Product

Table 92. Corden Pharma Revenue in Organoids LNP Business (2020-2025) & (US$ Million)

Table 93. Corden Pharma Recent Development

Table 94. Genevant Sciences Company Details

Table 95. Genevant Sciences Business Overview

Table 96. Genevant Sciences Organoids LNP Product

Table 97. Genevant Sciences Revenue in Organoids LNP Business (2020-2025) & (US$ Million)

Table 98. Genevant Sciences Recent Development

Table 99. Nippon Fine Chemical Company Details

Table 100. Nippon Fine Chemical Business Overview

Table 101. Nippon Fine Chemical Organoids LNP Product

Table 102. Nippon Fine Chemical Revenue in Organoids LNP Business (2020-2025) & (US$ Million)

Table 103. Nippon Fine Chemical Recent Development

Table 104. Polymun Scientific Company Details

Table 105. Polymun Scientific Business Overview

Table 106. Polymun Scientific Organoids LNP Product

Table 107. Polymun Scientific Revenue in Organoids LNP Business (2020-2025) & (US$ Million)

Table 108. Polymun Scientific Recent Development

Table 109. Catalent Company Details

Table 110. Catalent Business Overview

Table 111. Catalent Organoids LNP Product

Table 112. Catalent Revenue in Organoids LNP Business (2020-2025) & (US$ Million)

Table 113. Catalent Recent Development

Table 114. Creative Biolabs Company Details

Table 115. Creative Biolabs Business Overview

Table 116. Creative Biolabs Organoids LNP Product

Table 117. Creative Biolabs Revenue in Organoids LNP Business (2020-2025) & (US$ Million)

Table 118. Creative Biolabs Recent Development

Table 119. GenScript Company Details

Table 120. GenScript Business Overview

Table 121. GenScript Organoids LNP Product

Table 122. GenScript Revenue in Organoids LNP Business (2020-2025) & (US$ Million)

Table 123. GenScript Recent Development

Table 124. WuXi STA Company Details

Table 125. WuXi STA Business Overview

Table 126. WuXi STA Organoids LNP Product

Table 127. WuXi STA Revenue in Organoids LNP Business (2020-2025) & (US$ Million)

Table 128. WuXi STA Recent Development

Table 129. Research Programs/Design for This Report

Table 130. Key Data Information from Secondary Sources

Table 131. Key Data Information from Primary Sources

Table 132. Authors List of This Report

List of Figures

Figure 1. Organoids LNP Picture

Figure 2. Global Organoids LNP Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Organoids LNP Market Share by Type: 2024 VS 2031

Figure 4. Solid Lipid Nanoparticles (SLN) Features

Figure 5. Nanostructured Lipid Carriers (NLC) Features

Figure 6. Liposomes Features

Figure 7. Other Features

Figure 8. Global Organoids LNP Market Size Comparison by Organoid Model Type (2020-2031) & (US$ Million)

Figure 9. Liver Organoids Features

Figure 10. Intestinal Organoids Features

Figure 11. Kidney Organoids Features

Figure 12. Brain Organoids Features

Figure 13. Other Features

Figure 14. Global Organoids LNP Market Size Comparison by Application Area (2020-2031) & (US$ Million)

Figure 15. Drug Discovery Features

Figure 16. Gene Therapy Research Features

Figure 17. Regenerative Medicine Features

Figure 18. Personalized Medicine Features

Figure 19. Global Organoids LNP Market Size by Application (2020-2031) & (US$ Million)

Figure 20. Global Organoids LNP Market Share by Application: 2024 VS 2031

Figure 21. mRNA Delivery Case Studies

Figure 22. siRNA/miRNA Delivery Case Studies

Figure 23. Other Case Studies

Figure 24. Organoids LNP Report Years Considered

Figure 25. Global Organoids LNP Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 26. Global Organoids LNP Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 27. Global Organoids LNP Market Share by Region: 2024 VS 2031

Figure 28. Global Organoids LNP Market Share by Players in 2024

Figure 29. Global Organoids LNP Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 30. The Top 10 and 5 Players Market Share by Organoids LNP Revenue in 2024

Figure 31. North America Organoids LNP Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. North America Organoids LNP Market Share by Country (2020-2031)

Figure 33. United States Organoids LNP Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Canada Organoids LNP Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Europe Organoids LNP Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Europe Organoids LNP Market Share by Country (2020-2031)

Figure 37. Germany Organoids LNP Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. France Organoids LNP Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. U.K. Organoids LNP Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Italy Organoids LNP Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Russia Organoids LNP Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Ireland Organoids LNP Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Asia-Pacific Organoids LNP Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Asia-Pacific Organoids LNP Market Share by Region (2020-2031)

Figure 45. China Organoids LNP Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Japan Organoids LNP Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. South Korea Organoids LNP Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Southeast Asia Organoids LNP Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. India Organoids LNP Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Australia & New Zealand Organoids LNP Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Latin America Organoids LNP Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Latin America Organoids LNP Market Share by Country (2020-2031)

Figure 53. Mexico Organoids LNP Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Brazil Organoids LNP Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Middle East & Africa Organoids LNP Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. Middle East & Africa Organoids LNP Market Share by Country (2020-2031)

Figure 57. Israel Organoids LNP Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 58. Saudi Arabia Organoids LNP Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 59. UAE Organoids LNP Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 60. Croda Revenue Growth Rate in Organoids LNP Business (2020-2025)

Figure 61. Evonik Health Care Revenue Growth Rate in Organoids LNP Business (2020-2025)

Figure 62. Cytiva Revenue Growth Rate in Organoids LNP Business (2020-2025)

Figure 63. STEMCELL Technologies Revenue Growth Rate in Organoids LNP Business (2020-2025)

Figure 64. Acuitas Therapeutics Revenue Growth Rate in Organoids LNP Business (2020-2025)

Figure 65. Merck KGaA Revenue Growth Rate in Organoids LNP Business (2020-2025)

Figure 66. Corden Pharma Revenue Growth Rate in Organoids LNP Business (2020-2025)

Figure 67. Genevant Sciences Revenue Growth Rate in Organoids LNP Business (2020-2025)

Figure 68. Nippon Fine Chemical Revenue Growth Rate in Organoids LNP Business (2020-2025)

Figure 69. Polymun Scientific Revenue Growth Rate in Organoids LNP Business (2020-2025)

Figure 70. Catalent Revenue Growth Rate in Organoids LNP Business (2020-2025)

Figure 71. Creative Biolabs Revenue Growth Rate in Organoids LNP Business (2020-2025)

Figure 72. GenScript Revenue Growth Rate in Organoids LNP Business (2020-2025)

Figure 73. WuXi STA Revenue Growth Rate in Organoids LNP Business (2020-2025)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions